Genprex financials
$2.85+1.42%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating income | -$15.5M | -$21.2M | -$31.1M | -$23.8M | -$20.7M | -$18.0M | -$10.7M | -$12.4M |
| Net income | -$16.2M | -$21.4M | -$30.9M | -$23.7M | -$20.7M | -$17.9M | -$10.7M | -$12.4M |
| Net margin | — | — | — | — | — | — | — | — |
| Diluted EPS | $-382.80 | $-5871.58 | $-24816.00 | $-21780.00 | $-19360.00 | $-22440.00 | $-29040.00 | $-39600.00 |
| EBITDA | -$15.5M | -$21.2M | -$31.0M | -$23.8M | -$20.6M | -$17.9M | -$10.7M | -$12.4M |
| Operating cash flow | -$15.3M | -$17.9M | -$24.7M | -$17.6M | -$14.3M | -$13.9M | -$6.9M | -$6.8M |
| Free cash flow | -$15.3M | -$17.9M | -$24.7M | -$17.6M | -$14.3M | -$16.2M | -$7.8M | -$6.9M |
| Diluted shares | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.8M | $1.6M | $6.7M | $21.0M | $38.6M | $27.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $10.2M | $4.1M | $10.7M | $25.1M | $42.9M | $31.4M |
| Total liabilities | $2.2M | $2.5M | $3.3M | $2.8M | $1.6M | $450.7K |
| Shareholders' equity | $8.0M | $1.6M | $7.4M | $22.3M | $41.3M | $30.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology